Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuling Zhao

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Nanomedicine (London, England)|November 19, 2013
Macrophages offer a paradigm switch for CNS delivery of therapeutic proteinsNatalia L Klyachko, Matthew J Haney, Yuling Zhao, et al.
Scientific Reports|July 18, 2020
Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routesMatthew J Haney, Yuling Zhao, James Fay, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 29, 2022
Corrigendum to "GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice", [J Control Release, 315 (2019) 139-149]Yuling Zhao, Matthew J Haney, Yeon S Jin, et al.
Nanomedicine (London, England)|April 1, 2011
Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cellsMatthew J Haney, Yuling Zhao, Shu Li, et al.
Cells|June 24, 2022
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson DiseaseYuling Zhao, Matthew J Haney, John K Fallon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2019
GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) miceYuling Zhao, Matthew J Haney, Yeon S Jin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 21, 2015
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cellsMyung Soo Kim, Matthew J Haney, Yuling Zhao, et al.
Cell|March 19, 2024
RNA damage compartmentalization by DHX9 stress granulesYilong Zhou, Amol Panhale, Maria Shvedunova, et al.
Nanomedicine (London, England)|December 25, 2010
Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticlesYuling Zhao, Matthew J Haney, Natalia L Klyachko, et al.
Plos One|April 27, 2013
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesMatthew J Haney, Yuling Zhao, Emily B Harrison, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Nanomedicine (London, England)|November 19, 2013
Macrophages offer a paradigm switch for CNS delivery of therapeutic proteinsNatalia L Klyachko, Matthew J Haney, Yuling Zhao, et al.
Scientific Reports|July 18, 2020
Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routesMatthew J Haney, Yuling Zhao, James Fay, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 29, 2022
Corrigendum to "GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice", [J Control Release, 315 (2019) 139-149]Yuling Zhao, Matthew J Haney, Yeon S Jin, et al.
Nanomedicine (London, England)|April 1, 2011
Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cellsMatthew J Haney, Yuling Zhao, Shu Li, et al.
Cells|June 24, 2022
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson DiseaseYuling Zhao, Matthew J Haney, John K Fallon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2019
GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) miceYuling Zhao, Matthew J Haney, Yeon S Jin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 21, 2015
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cellsMyung Soo Kim, Matthew J Haney, Yuling Zhao, et al.
Cell|March 19, 2024
RNA damage compartmentalization by DHX9 stress granulesYilong Zhou, Amol Panhale, Maria Shvedunova, et al.
Nanomedicine (London, England)|December 25, 2010
Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticlesYuling Zhao, Matthew J Haney, Natalia L Klyachko, et al.
Plos One|April 27, 2013
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesMatthew J Haney, Yuling Zhao, Emily B Harrison, et al.
Pageof 16